Epilepsy is the most common neurological disorder in humans. People with epilepsy are more likely to die prematurely than those without epilepsy, with the most common epilepsy-related category of death being sudden unexpected death in epilepsy (SUDEP). The central mechanisms underlying the fatal process remain unclear, but cardiac and respiratory mechanisms appear to be involved. Recently, cerebellar, thalamic, basal ganglia and limbic brain structures have been shown to be implicated in respiratory and cardiac rate regulation. We discuss here the potential mechanisms underlying the fatal process, with a description of cerebellar actions likely failing in that SUDEP process. Key words: SUDEP, epilepsy, cerebellum, respiratory mechanisms, seizures.
Epilepsies are one of the most common serious brain disorders, and affects approximately 50 million people worldwide 1 . Almost 25% of people developing epilepsy evolve with medically intractable epilepsy, with a major proportion of patients in the paediatric group [2] [3] [4] . Unfortunately, approximately one in 1000 patients with chronic epilepsy will die suddenly, unexpectedly, and without explanation each year 5 ; suden unexpected death in epilepsy (SUDEP) is considered the most important direct epilepsy-related cause of death 6 . A number of associated factors for SUDEP have been assessed, with these factors including: refractoriness of the epileptic condition, presence of generalized tonic-clonic seizures, antiepileptic medication (polytherapy with antiepileptic drugs), duration of the seizure disorder, early onset of epilepsy, and young age 7, 8 . Understanding the mechanisms underlying SUDEP may lead to identification of previously-unrecognized risk factors that are more amenable to correction 9 . Although different mechanisms may play separate roles in different cases 7 , the two major domains of potential mechanisms SUDEP: cerebellar mechanisms? Scorza et al.
of SUDEP are autonomic, i.e., cardiovascular, and respiratory 9 . Pulmonary abnormalities, such as increased lung weight, pulmonary congestion, or edema, consequences of unrestrained autonomic action, appear frequently in postmortem examinations of SUDEP victims 9 . Both central and obstructive apnea can occur during or immediately after a seizure 10 . Obstructive apnea will usually complicate a generalized tonic-clonic seizure, whereas central apnea may occur during both partial and generalized seizures 10, 11 . Central hypoventilation and apnoea accompany generalized status epilepticus, and may be an important mechanism in a sheep model of epileptic sudden death 12 . A cardiovascular collapse, either from arrhythmia from the extreme sympathetic activation during a seizure, or from hypotension induced by asystole from profound vagal activation during seizure discharge is also possible.
Brain regions and SUDEP
Disorders of the central nervous system (CNS) can alter cardiovascular function 13 , and localized brain lesions or dysfunction can modify functional cardiovascular and respiratory alterations. Recognition of these interactions has led to significant advances in understanding the brain sites involved with cardiovascular and respiratory control in adult humans 14 , and many of these sites lie outside classical "respiratory" or "cardiovascular" areas. Several of the sites are limbic regions, which are especially susceptible to seizure discharge, and other sites lie in the cerebellum, a structure ordinarily not considered as mediating breathing control, but now is recognized as a significant respiratory and cardiovascular regulatory site [14] [15] [16] [17] [18] [19] [20] . Cerebellar cardiovascular regulatory areas can dampen, i.e., limit extreme changes in hypotension or hypertension to ensure survival. The cerebellum is also responsible for integration of rapid cardiac response to respiratory oscillations 18 , and cerebellar deep nuclei sense CO 2 and respond to prolonged apnea [16] [17] [18] [19] [20] . Cerebellar roles in compensating for extreme changes in blood pressure or breathing suggests that failure within that structure would enhance the potential for SUDEP.
Of interest, cerebellar abnormalities are quite common in patients with chronic epilepsy, especially when patients are submitted to high doses of antiepileptic drugs, with these patients being at increased risk for SUDEP. Recently, we followed a 9-year-old boy with a history of an uneventful pregnancy, born from a breech delivery with Apgar scores of 5 (first minute) and 8 (fifth minute) and who developed with moderate neurodevelopment delay. Medically-intractable epileptic seizures started at the age of five months. His seizures consisted of daily infantile spasms, and were treated with valproic acid, vigabatrin and predinisone without response. From age 3 to 5 years, he used a ketogenic diet, and was seizure-free. Six months after the ketogenic diet withdrawal (his parents decided not to continue with the regimen), tonic seizures relapsed, with a frequency of one to two weekly. Magnetic resonance imaging revealed diffuse cerebral and cerebellar atrophy. The electroencephalogram consisted of mild brain disorganized activity and rare multifocal spikes. An investigation for metabolic inborn errors was normal. The patient was using phenobarbital (150 mg per day), and died during a prolonged tonic seizure. The patient was in an otherwise good state of health, and post-mortem examination did not reveal any abnormalities. Considering this evidence, the cause of death was considered a SUDEP.
In this patient with poorly controlled epilepsy who died suddenly during a tonic-clonic seizure, loss of respiratory or cardiovascular regulation may be implicated, and may be induced by cerebellar abnormalities unable to perform normal regulatory functions. Several potential processes may have occurred; extreme hypotension or arrhythmia, sustained apneusis, or prolonged apnea, all outcomes in which protective cerebellar compensatory action could have been beneficial if cerebellar structures were not damaged. The precise mechanisms underlying the processes are unclear; however, several pieces of evidence suggest the relationship we propose and the rationale for active pursuit.
A major proportion of patients with epilepsy are pediatric cases (18 years old or less), and approximately 25% of those patients have medically intractable epilepsy 21 . Only 10-20% of the children with epilepsy who continue to present with active epilepsy in adulthood will have spontaneous seizure remission, suggesting that early attempts to control the epilepsy should be pursued [22] [23] [24] . Epilepsies in the pediatric group may be frequently associated with known potentially risk factors for SUDEP. SUDEP remains a controversial and enigmatic syndrome, particularly in children where the incidence, prevalence and risk factors may differ from adults 25 . Contrary to the widespread opinion that SUDEP does not occur in children, the age of reported cases has ranged from 8 months to 83 years 26 . The incidence of SUDEP in children and adolescents is highly variable, but it is thought to be extremely rare in community-based studies [27] [28] [29] . Nevertheless, SUDEP has been identified as being the cause of mortality in 12% of the children followed over a five-year period time, suggesting that the incidence may not be so rare 30 . The respiratory changes accompanying increased seizure frequency also suggest SUDEP in this case. This child presented with high seizure frequency (one to two weekly) before death. Most studies that include information on seizure control report a moderate or high SUDEP: cerebellar mechanisms? Scorza et al.
seizure frequency among SUDEP cases 26 , and SUDEP is considered rare in patients in remission, with only a few such cases reported 26 . Although few data exist about the risk of SUDEP in children, a recent study by our research group demonstrated that increased SUDEP occurrence appeared in children unresponsive to antiepileptic therapy, with no increase in risk observed in patients who remained seizure free 31 . An additional important issue is evidence that phenytoin can exert toxic effects on the cerebellum in patients with epilepsy 32 ; the toxicity is associated with ataxia, tremor, nystagmus and diplopia 32, 33 . Furthermore, cerebellar atrophy can occur in phenytoin-exposed patients with epilepsy in the absence of generalised tonicclonic seizures or pre-existent brain damage 32, 34, 35 . Since the child evaluated in our study did not use phenytoin in his antiepileptic drug therapy schedule, our research group did not consider this issue.
Cerebellar and autonomic process
The principal evidence for cerebellar involvement was diffuse cerebellar atrophy revealed by magnetic resonance imaging. The evidence for a cerebellar role in breathing is substantial. Chokroverty and colleagues demonstrated a high incidence of obstructive sleep apnea in adults accompanying olivopontocerebellar degeneration 36 . Massive intracerebellar hemorrhage (destruction of at least one-third of cerebellar tissue) is frequently accompanied by sudden death during sleep in low-birthweight infants 37 . Cerebellar damage, delayed development 38 , or injury to a principal afferent structure, the olivary nucleus 39 are all pathological findings reported in the sudden infant death syndrome (SIDS), a sleeprelated syndrome suspected of resulting from a failure of enhanced respiratory efforts to compensate for transient hypotension or an inability to recover from an excessive CO 2 challenge 14, 40, 41 . Similar cerebellar injury was reported in patients with congenital central hypoventilation syndrome, a condition with deficient response to hypercapnia and hypoxia, with possible dysfunction of cerebellar, thalamic, basal ganglia and limbic structures 18, 41 . The deep cerebellar nuclei respond to chemosensitive stimuli in both animal 16, 17 and human models 18 . Moreover, the fastigial deep cerebellar nuclei in the cerebellum, when damaged, lead to death following hypotension in animals 19 . The cerebellum, of course, does not act in isolation from its brainstem and other projections in these disrupted actions; compensatory action to recover from extreme hypotension is mediated through cerebellar, vestibular, reticular formation, and ventral medullar blood pressure regulatory nuclei 41 , and chemoreceptor mediation is mediated through medullary afferent and solitary tract nuclei, as well as through respiratory motor structures 17 . From this evidence, we suggest that a relationship exists between cerebellar abnormalities and SUDEP.
Cerebellar atrophy is a common finding in people suffering from epilepsy, including temporal lobe epilepsy [42] [43] [44] , the most common form of partial epilepsy 45 and the commonest form of drug-refractory epilepsy 42 . Although the precise mechanisms are still debated, cerebellar volume reduction in people with epilepsy is often attributed to age, presence of generalized tonic-clonic seizures, duration of epilepsy, antiepileptic medication, or the seizure activity itself [42] [43] [44] 46, 47 . Specht and colleagues demonstrated in 1997 that cerebellar atrophy diagnosed by MRI was a frequent finding in surgically treated patients with temporal lobe epilepsy 44 , and concluded that increased age, presence of generalized seizures, and intellectual disability were the principal factors associated with cerebellar volume losses in their patients 44 . Botez and co-workers studied 134 adult patients with epilepsy using high-resolution CT scans, and found a higher incidence of cerebellar atrophy with longer duration of epilepsy and treatment with phenytoin 48 . Convincing evidence exists that prolonged phenytoin use, or a single episode of phenytoin intoxication can elicit severe and irreversible cerebellar atrophy 42, 44, 49, 50 . Although chronic cerebellar stimulation suggests an inhibitory role for the cerebellum as an intervention for intractable seizures, cerebellar volume reduction may reduce these effects in patients with chronic epilepsy 42, 44, 51 . Furthermore, cerebellar atrophy, i.e., reductions in hemispheric Purkinje cell density, occurs in epilepsy patients 52 , a finding confirmed by the prominent expression of c-Jun staining of cerebellar Purkinje cells in some SUDEP cases 53 . The mechanisms underlying cerebellar volume reduction in people with epilepsy may be similar to the processes that result in risk factors for SUDEP. Cerebellar atrophy may lead to an inability to recover from apnea or apneusis, or failure to recover from extreme hypotension or arrhythmia, ultimately resulting in SUDEP in individuals with refractory epilepsy. There are few studies that examine neuropathology with SUDEP; some studies suggest amygdala central nucleus damage may contribute to SUDEP, especially since that structure can play a role in respiratory timing [7] [8] [9] [10] [11] . Despite some progress, SUDEP remains a significant clinical problem. Unfortunately, all the risk factors, mechanisms, and specific methods to prevent SUDEP are yet to be found 54 . Structural, functional and genetic factors are probable involved, and specific brain regions may be directly related. Considering these factors, determination of which brain regions are mainly involved in SUDEP is essential to the understanding of SUDEP mechanisms and prevention. The study of cerebellar SUDEP: cerebellar mechanisms? Scorza et al.
functioning in patients with epilepsy may be of particularly interest.
The American Epilepsy Society and the Epilepsy Foundation Joint Task Force convened a task force to assess the state of knowledge (research directions, social, cultural and educational efforts) on SUDEP 55 . The potential functional significance of the cerebellum in respiratory and cardiovascular dysfunction in people with chronic epilepsy is that the structure is a brain area with roles for respiratory and cardiovascular regulation, dysfunction of which can compromise life, and these issues represent a specific line of research in the SUDEP field that should be investigated.
